The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
Open accessAbstract
Animal cells harbour multiple innate effector mechanisms that inhibit virus replication. For the pathogenic retrovirus human immunodeficiency virus type 1 (HIV-1), these include widely expressed restriction factors, such as APOBEC3 proteins, TRIM5-α, BST2 (refs 4, 5) and SAMHD1 (refs 6, 7), as well as additional factors that are stimulated by type 1 interferon (IFN). Here we use both ectopic expression and gene-silencing experiments to define the human dynamin-like, IFN-induced myxovirus resistance 2 (MX2, also known as MXB) protein as a potent inhibitor of HIV-1 infection and as a key effector of IFN-α-mediated resistance to HIV-1 infection. MX2 suppresses infection by all HIV-1 strains tested, has equivalent or reduced effects on divergent simian immunodeficiency viruses, and does not inhibit other retroviruses such as murine leukaemia virus. The Capsid region of the viral Gag protein dictates susceptibility to MX2, and the block to infection occurs at a late post-entry step, with both the nuclear accumulation and chromosomal integration of nascent viral complementary DNA suppressed. Finally, human MX1 (also known as MXA), a closely related protein that has long been recognized as a broadly acting inhibitor of RNA and DNA viruses, including the orthomyxovirus influenza A virus, does not affect HIV-1, whereas MX2 is ineffective against influenza virus. MX2 is therefore a cell-autonomous, anti-HIV-1 resistance factor whose purposeful mobilization may represent a new therapeutic approach for the treatment of HIV/AIDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Self-citationTetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,050
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Donnelly, M. L. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1013 · Cited by 798
Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
Yee, J. K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J. C., & Friedmann, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9564 · Cited by 487
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Self-citationAntiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
Self-citationSchaller, T., Ocwieja, K. E., Rasaiyaah, J., Price, A. J., Brady, T. L., Roth, S. L., Hué, S., Fletcher, A. J., Lee, K., KewalRamani, V. N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002439 · Cited by 470
Self-citationFlexible Use of Nuclear Import Pathways by HIV-1
Lee, K., Ambrose, Z., Martin, T. D., Oztop, I., Mulky, A., Julias, J. G., Vandegraaff, N., Baumann, J. G., Wang, R., Yuen, W., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.02.007 · Cited by 460
Sauter, D., Schindler, M., Specht, A., Landford, W. N., Münch, J., Kim, K.-A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B. F., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.10.004 · Cited by 429
Pavlovic, J., Zürcher, T., Haller, O., & Staeheli, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3370-3375.1990 · Cited by 401
Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
Haller, O., & Kochs, G. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0076 · Cited by 366
Ochsenbauer, C., Edmonds, T. G., Ding, H., Keele, B. F., Decker, J., Salazar, M. G., Salazar-Gonzalez, J. F., Shattock, R., Haynes, B. F., Shaw, G. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06157-11 · Cited by 342
Fouchier, R. A. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4531 · Cited by 339
RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
IFN-Inducible GTPases in Host Cell Defense
Kim, B.-H., Shenoy, A. R., Kumar, P., Bradfield, C. J., & MacMicking, J. D. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.007 · Cited by 283
Use of the viral 2A peptide for bicistronic expression in transgenic mice
Trichas, G., Begbie, J., & Srinivas, S. (2008) · BMC Biology · doi:10.1186/1741-7007-6-40 · Cited by 236
Optimizing the noise versus bias trade-off for Illumina Whole Genome Expression Beadchips
Shi, W., Oshlack, A., & Smyth, G. K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq871 · Cited by 225
Gao, S., von der Malsburg, A., Dick, A., Faelber, K., Schröder, G. F., Haller, O., Kochs, G., & Daumke, O. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.012 · Cited by 222
A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration
O'Doherty, U., Swiggard, W. J., Jeyakumar, D., McGain, D., & Malim, M. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10942-10950.2002 · Cited by 209
Self-citationA functional GTP-binding motif is necessary for antiviral activity of Mx proteins
Pitossi, F., Blank, A., Schröder, A., Schwarz, A., Hüssi, P., Schwemmle, M., Pavlovic, J., & Staeheli, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6726-6732.1993 · Cited by 182
Schindler, M., Würfl, S., Benaroch, P., Greenough, T. C., Daniels, R., Easterbrook, P., Brenner, M., Münch, J., & Kirchhoff, F. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10548-10556.2003 · Cited by 176
Meylan, P. R., Guatelli, J., Munis, J. R., Richman, D. D., & Kornbluth, R. S. (1993) · Virology · doi:10.1006/viro.1993.1110 · Cited by 166
Bamming, D., & Horvath, C. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807365200 · Cited by 163
Goujon, C., & Malim, M. H. (2010) · Journal of Virology · doi:10.1128/jvi.00854-10 · Cited by 159
Self-citationMitchell, P. S., Patzina, C., Emerman, M., Haller, O., Malik, H. S., & Kochs, G. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.005 · Cited by 142
Melén, K., Keskinen, P., Ronni, T., Sareneva, T., Lounatmaa, K., & Julkunen, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23478 · Cited by 138
Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles
Mangeot, P.-E., Dollet, S., Girard, M., Ciancia, C., Joly, S., Peschanski, M., & Lotteau, V. (2011) · Molecular Therapy · doi:10.1038/mt.2011.138 · Cited by 133
The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating
Shah, V. B., Shi, J., Hout, D. R., Öztop, I., Krishnan, L., Ahn, J., Shotwell, M. S., Engelman, A., & Aiken, C. (2012) · Journal of Virology · doi:10.1128/jvi.07177-11 · Cited by 129
High Levels of Transduction of Human Dendritic Cells with Optimized SIV Vectors
Mangeot, P.-E., Duperrier, K., Négre, D., Boson, B., Rigal, D., Cosset, F., & Darlix, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0541 · Cited by 128
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo
Pillai, S. K., Abdel‐Mohsen, M., Guatelli, J., Skasko, M., Monto, A., Fujimoto, K., Yukl, S. A., Greene, W. C., Kovari, H., Rauch, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111573109 · Cited by 124
Asmuth, D. M., Murphy, R. L., Rosenkranz, S. L., Lertora, J. J. L., Kottilil, S., Cramer, Y. S., Chan, E. S., Schooley, R. T., Rinaldo, C. R., Thielman, N. M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652420 · Cited by 122
Ponten, A., Sick, C., Weeber, M., Haller, O., & Kochs, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2591-2599.1997 · Cited by 119
King, M. C., Raposo, G., & Lemmon, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403167101 · Cited by 118
Simon, J. H., Southerling, T. E., Peterson, J., Meyer, B. E., & Malim, M. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4166-4172.1995 · Cited by 116
Self-citationMutational analysis of influenza virus promoter elements in vivo
Neumann, G., & Hobom, G. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-7-1709 · Cited by 110
Restriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5α Proteins
Saenz, D. T., Teo, W., Olsen, J. C., & Poeschla, E. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15175-15188.2005 · Cited by 109
Markusic, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni062 · Cited by 78
Further Investigation of Simian Immunodeficiency Virus Vif Function in Human Cells
Gaddis, N., Sheehy, A. M., Ahmad, K. M., Swanson, C. M., Bishop, K. N., Beer, B., Marx, P. A., Gao, F., Bibollet‐Ruche, F., Hahn, B. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12041-12046.2004 · Cited by 70
Self-citationEvidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection
Goujon, C., Schaller, T., Galão, R. P., Amie, S. M., Kim, B., Olivieri, K. C., Neil, S. J. D., & Malim, M. H. (2013) · Retrovirology · doi:10.1186/1742-4690-10-23 · Cited by 59
Self-citationTransduction of Nondividing Human Macrophages with Gammaretrovirus-Derived Vectors
Jarrosson, L., Goujon, C., Bernaud, J., Rigal, D., Darlix, J., & Cimarelli, A. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1152-1159.2006 · Cited by 52
Self-citationCauldwell, A. V., Moncorgé, O., & Barclay, W. (2012) · Journal of Virology · doi:10.1128/jvi.02597-12 · Cited by 46
Self-citationO’Rourke, J. P., Newbound, G. C., Kohn, D. B., Olsen, J. C., & Bunnell, B. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1510-1515.2002 · Cited by 41
Adaptation to the Interferon-Induced Antiviral State by Human and Simian Immunodeficiency Viruses
Bitzegeio, J., Sampias, M., Bieniasz, P. D., & Hatziioannou, T. (2013) · Journal of Virology · doi:10.1128/jvi.03219-12 · Cited by 32
Evidence for a Different Susceptibility of Primate Lentiviruses to Type I Interferons
Cordeil, S., Nguyen, X.-N., Berger, G., Durand, S., Ainouze, M., & Cimarelli, A. (2012) · Journal of Virology · doi:10.1128/jvi.02553-12 · Cited by 22
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Innate immunity to influenza virus infection
Iwasaki, A., & Pillai, P. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3665 · Cited by 1,068
Interferon-Stimulated Genes: What Do They All Do?
Schoggins, J. W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015756 · Cited by 1,036
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Sandler, N. G., Bosinger, S. E., Estes, J. D., Zhu, R. T. R., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K. N., del Prete, G. Q., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 461
Mx GTPases: dynamin-like antiviral machines of innate immunity
Haller, O., Staeheli, P., Schwemmle, M., & Kochs, G. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2014.12.003 · Cited by 456
Metadata
- Authors
- Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hué, S., Barclay, W. S., Schulz, R., & Malim, M. H.
- Venue
- Nature
- Published
- 2013-09-18
- Volume
- 502
- Issue
- 7472
- Pages
- 559-562
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2043726848
- Cited by
- 583
- References
- 58
- FWCI
- 24.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.